General Information of DTT (ID: TTUO98L)

DTT Name Angiopoietin-related protein 3 (ANGPTL3) DTT Info
Gene Name ANGPTL3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Evinacumab DMBLX7U Hypercholesterolaemia 5C80.0 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AKCEA-ANGPTL3-LRX DMR8W7Y Cardiovascular disease BA00-BE2Z Phase 2 [2]
LNA043 DMDHVK8 Knee osteoarthritis FA01 Phase 2 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2021
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial. Nat Med. 2022 Dec;28(12):2633-2645.